Lower Extremity Review
Facemasks are the most widely used tool for mitigating the spread of the COVID-19 pandemic. Decreased disease severity by the wearer has also been linked to the use of cloth facemasks. This well-documented finding is surprising considering that such masks are poor at filtering the smallest aerosol particles, which can reach the lower respiratory tract and have been associated with severe disease.
The long-awaited vaccines to ward off COVID-19 may be getting into people’s arms, but clinicians’ offices around the country are still asking, “are we doing all we can to keep our patient safe?” In addition to the current procedures of cleaning between patients with ultraviolet light or harmful chemicals, new technology is coming online to help answer that question.
Everyday glasses—the kind worn by hipsters and nerds alike—may do more than just improve eyesight. Two recent studies are reporting that wearing eyeglasses—to the tune of 8 or more hours a day—appears to slow or even prevent the wearer from becoming infected with SARS-CoV-2, the virus that causes COVID-19.
The COVID-19 pandemic has disrupted healthcare around the world. The need for solutions today—for better predictive models, better diagnostics, more and better treatments—is driving the adoption of artificial intelligence (AI) as a necessary…
According to an AI platform developed by researchers at the Cleveland Clinic’s Lerner Research Institute, the hormone that helps regulate sleep—melatonin—may be a novel treatment for COVID-19.
A simple test—akin to the well-known breathalyser to detect blood alcohol—may be able to “smell” COVID-19 according to Indonesian researchers. Using AI in the form of an electronic nose, the GeNose C-19 device is able to identify elements that are unique to COVID-19.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of COVID-19, emerged from a zoonotic source in China in late 2019. Its transmission has been ineffectively controlled and the world has been immersed in a COVID-19 pandemic since early 1st quarter of 2020.
Since the spring, it has been demonstrated that masks are a critical deterrent to the spread of SARS-CoV-2, the virus that leads to COVID-19, the worldwide pandemic that has claimed more than 240,000 American lives, and more than 1.25 million lives globally. Experts are agreed now that transmission of the virus is predominately by respiratory droplets when people sneeze, sing, talk, or breathe.
While COVID-19 is known to affect the body in numerous ways that are yet not clearly understood, several researchers have begun to focus on what is known: SARS-CoV-2, the virus that causes COVID-19, starts by infecting certain cells in the nasal passage. Stopping, or at least slowing this initial foothold may prove a powerful strategy for taming this pandemic.
While COVID-19 is known to affect the body in numerous ways that are yet not clearly understood, several researchers have begun to focus on what is known: SARS-CoV-2, the virus that causes COVID-19, starts by infecting certain cells in the nasal passage. Stopping, or at least slowing this initial foothold may prove a powerful strategy for taming this pandemic.
As the COVID-19 pandemic continues to rage, so-called “COVID toes” continue to be reported around the world. These dermatologic manifestations were catalogued in a recent international registry-based case series, adding to the emerging evidence that pernio-like lesions may be a cutaneous manifestation of COVID-19.
How Right Now is an initiative to address people’s feelings of grief, loss, and worry during the COVID-19 pandemic. Overall, it aims to increase people’s ability to adapt and be resilient during this time. The How Right Now initiative is funded by the CDC Foundation. How Right Now has four primary audiences, which include: adults over 65 and their caregivers; people with pre-existing physical and…
While our understanding of why COVID-19 affects different individuals so dramatically remains vexing, clinicians at Montefiore Medical Center in the Bronx, New York, put together an observational study to determine whether early treatment with glucocorticoids is associated with reduced mortality or the need for…
While our understanding of why COVID-19 affects different individuals so dramatically remains vexing, clinicians at Montefiore Medical Center in the Bronx, New York, put together an observational study to determine whether early treatment with glucocorticoids is associated with reduced mortality or the need for…
While the respiratory pathology of COVID-19 has taken center stage over the last 6 months, data is beginning to accrue related to its extrapulmonary manifestations, and they are many and widely variable.
Join
Stay in the loop with the latest news and updates! Subscribe now to receive exclusive content, special offers, and important announcements straight to your inbox. Don’t miss out – join our community today for all the latest updates delivered directly to you.